Realcan Pharmaceutical Group Co., Ltd. (SHE:002589)
China flag China · Delayed Price · Currency is CNY
3.030
+0.010 (0.33%)
Jun 4, 2025, 2:45 PM CST

SHE:002589 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2015 - 2019
Net Income
19.6220.6220.32-1,831131.18261.3
Upgrade
Depreciation & Amortization
164.77164.77219.68283.88319.22291.41
Upgrade
Other Amortization
51.2851.2825.7532.8844.4246.39
Upgrade
Loss (Gain) From Sale of Assets
-18.94-18.947.921-3.06-3.78
Upgrade
Asset Writedown & Restructuring Costs
0.610.614.9147.8339.925.43
Upgrade
Loss (Gain) From Sale of Investments
-114.4-114.4-424.59656.44-103.46-226.57
Upgrade
Provision & Write-off of Bad Debts
43.1243.1210.01159.22158.77123.63
Upgrade
Other Operating Activities
326.41228.3651.211,036822.641,031
Upgrade
Change in Accounts Receivable
61.0161.011,122-6,340-197.21-198.13
Upgrade
Change in Inventory
385.04385.04-165.26190.72476.9377.99
Upgrade
Change in Accounts Payable
-660.28-660.28-1,2196,314-1,069-1,254
Upgrade
Operating Cash Flow
257.56160.4482.47523.07442.95414.96
Upgrade
Operating Cash Flow Growth
-94.56%-84.23%18.09%6.75%-80.19%
Upgrade
Capital Expenditures
-123.18-111.53-298.38-170.96-461.09-640.15
Upgrade
Sale of Property, Plant & Equipment
-8.10.750.7183.9713.352.19
Upgrade
Cash Acquisitions
----70.37-173.27-358.5
Upgrade
Divestitures
156.39224.061,163982.5382.08313.89
Upgrade
Investment in Securities
106.9290.5-285.98-297.63-80.58-491.53
Upgrade
Other Investing Activities
-1.690.20.332.7720.4426.81
Upgrade
Investing Cash Flow
130.33203.98579.53592.96-583.51-972.71
Upgrade
Short-Term Debt Issued
-18,56820,7856,2718,4808,531
Upgrade
Long-Term Debt Issued
-2,7135,40611,15911,06613,059
Upgrade
Total Debt Issued
20,48121,28026,19117,43019,54721,591
Upgrade
Short-Term Debt Repaid
--18,310-22,609-14,030-12,372-3,460
Upgrade
Long-Term Debt Repaid
--2,963-3,975-4,347-6,824-9,802
Upgrade
Total Debt Repaid
-20,321-21,273-26,584-18,377-19,196-13,261
Upgrade
Net Debt Issued (Repaid)
160.416.96-393.11-947.42350.848,330
Upgrade
Issuance of Common Stock
78.6178.6126.368.74.248.56
Upgrade
Repurchase of Common Stock
-33.34-33.34-28.54-29.58-4.4-8.03
Upgrade
Common Dividends Paid
-204.67-198.71-201.69-154.31-316.31-346.56
Upgrade
Other Financing Activities
-18.44--80.15-402.52-84.78-9,065
Upgrade
Financing Cash Flow
-17.43-146.47-677.2-1,465-50.42-1,081
Upgrade
Foreign Exchange Rate Adjustments
---00-00
Upgrade
Net Cash Flow
370.46217.95-15.2-349.09-190.98-1,639
Upgrade
Free Cash Flow
134.3848.92-215.92352.11-18.13-225.19
Upgrade
Free Cash Flow Margin
1.74%0.61%-2.69%2.86%-0.09%-0.83%
Upgrade
Free Cash Flow Per Share
0.090.03-0.140.24-0.01-0.15
Upgrade
Cash Interest Paid
20.6820.6819.5736.5843.350.3
Upgrade
Cash Income Tax Paid
171.79165.85135.3398.68928.461,055
Upgrade
Levered Free Cash Flow
-924.63-106.62-3,6104,9205,678-2,201
Upgrade
Unlevered Free Cash Flow
-798.4714.55-3,4215,1756,024-1,817
Upgrade
Change in Net Working Capital
924.83132.593,334-5,097-5,6132,403
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.